kyvero
Market leaders

TCMD

Tactile Systems Technology, Inc. (TCMD)

Healthcare • Medical Devices

StockNasdaqGMUnited StatesUS87357P1003

27.06 USD +0.89% today Updated 13 Nov 2026 15:21

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Tactile Systems Technology, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 15:21. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 18 Feb 2027 in 97 days · 16:00 · estimate 0.60
Last results 0.33 vs 0.34 estimated 02 Nov 2026 · Miss -1.7%
Beat the estimate 8 of 12 4 missed · 0 in line
Average surprise +468.7% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

06 Nov 2023: estimate 0.02 06 Nov 2023: reported 0.85 11/23 20 Feb 2024: estimate 0.22 20 Feb 2024: reported 0.37 02/24 06 May 2024: estimate -0.01 06 May 2024: reported -0.05 05/24 05 Aug 2024: estimate 0.14 05 Aug 2024: reported 0.20 08/24 04 Nov 2024: estimate 0.17 04 Nov 2024: reported 0.25 11/24 18 Feb 2025: estimate 0.28 18 Feb 2025: reported 0.40 02/25 05 May 2025: estimate -0.06 05 May 2025: reported -0.11 05/25 04 Aug 2025: estimate 0.14 04 Aug 2025: reported 0.14 08/25 03 Nov 2025: estimate 0.21 03 Nov 2025: reported 0.36 11/25 17 Feb 2026: estimate 0.45 17 Feb 2026: reported 0.46 02/26 10 Aug 2026: estimate 0.17 10 Aug 2026: reported 0.36 08/26 02 Nov 2026: estimate 0.34 02 Nov 2026: reported 0.33 11/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
18 Feb 2027 16:00 0.60 — — Upcoming
02 Nov 2026 16:00 0.34 0.33 -1.7% Miss
10 Aug 2026 16:00 0.17 0.36 +111.8% Beat
04 May 2026 16:00 -0.04 — +106.9% —
17 Feb 2026 16:00 0.45 0.46 +3.4% Beat
03 Nov 2025 16:00 0.21 0.36 +75.6% Beat
04 Aug 2025 16:00 0.14 0.14 -3.5% Miss
05 May 2025 16:00 -0.06 -0.11 -69.7% Miss
18 Feb 2025 16:00 0.28 0.40 +43.3% Beat
04 Nov 2024 16:00 0.17 0.25 +44.8% Beat
05 Aug 2024 16:00 0.14 0.20 +46.2% Beat
06 May 2024 16:00 -0.01 -0.05 -255.3% Miss
20 Feb 2024 07:00 0.22 0.37 +74.3% Beat
06 Nov 2023 16:00 0.02 0.85 +5,555.3% Beat
07 Aug 2023 17:00 -0.02 0.04 +278.8% Beat
08 May 2023 16:00 -0.20 -0.03 +84.6% Beat
21 Feb 2023 07:00 0.14 0.29 +114.4% Beat
07 Nov 2022 16:00 -0.05 0.09 +268.2% Beat
01 Aug 2022 16:00 -0.07 -0.15 -94.0% Miss
02 May 2022 16:00 -0.20 -0.42 -106.8% Miss
22 Feb 2022 16:00 0.05 -0.28 -613.7% Miss
08 Nov 2021 16:00 0.12 -0.17 -241.7% Miss
02 Aug 2021 16:00 0.02 0.07 +250.0% Beat
03 May 2021 16:00 -0.19 -0.12 +35.7% Beat
23 Feb 2021 16:00 0.26 0.55 +111.5% Beat
02 Nov 2020 16:00 -0.06 0.12 +300.0% Beat
03 Aug 2020 16:00 -0.23 -0.72 -208.6% Miss
04 May 2020 08:00 -0.03 -0.07 -169.2% Miss
26 Feb 2020 16:00 0.27 0.26 -3.8% Miss
04 Nov 2019 16:00 0.11 0.12 +9.1% Beat
05 Aug 2019 16:00 0.08 0.14 +79.5% Beat
06 May 2019 16:00 -0.06 0.08 +229.0% Beat
28 Feb 2019 16:00 0.15 0.25 +65.0% Beat
05 Nov 2018 16:00 0.08 0.09 +12.5% Beat
06 Aug 2018 16:00 0.03 0.07 +198.8% Beat
07 May 2018 16:00 -0.14 — +100.0% —
26 Feb 2018 16:00 0.14 0.18 +33.3% Beat
07 Nov 2017 16:00 0.05 0.07 +40.0% Beat
07 Aug 2017 16:00 0.01 0.04 +320.0% Beat
08 May 2017 16:00 -0.16 -0.09 +43.8% Beat
27 Feb 2017 16:00 0.05 0.13 +160.0% Beat
10 Nov 2016 16:00 0.01 0.01 0.0% In line
07 Sep 2016 16:00 0.03 0.04 +50.0% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 329.5M +12.5% 19.1M 5.8% 0.82 +17.1% 40.3M
2024 293M +6.8% 17M 5.8% 0.70 -43.1% 38.1M
2023 274.4M +11.2% 28.5M 10.4% 1.23 +238.2% 33.4M
2022 246.8M — -17.9M -7.2% -0.89 — 3.3M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by week
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
09 Nov 2026 – 13 Nov 2026 In progress 26.29 27.34 25.95 27.06 +3.96% 802,078
02 Nov 2026 – 06 Nov 2026 23.49 28.71 21.00 26.03 +12.98% 2,082,400
26 Oct 2026 – 30 Oct 2026 23.73 24.58 22.85 23.04 -2.54% 859,900
19 Oct 2026 – 23 Oct 2026 22.53 23.87 22.45 23.64 +4.97% 794,800
12 Oct 2026 – 16 Oct 2026 22.28 23.41 22.03 22.52 +0.36% 919,000
05 Oct 2026 – 09 Oct 2026 22.30 22.69 21.66 22.44 +1.54% 1,222,900
28 Sep 2026 – 02 Oct 2026 22.69 23.30 21.61 22.10 -2.77% 1,064,800
21 Sep 2026 – 25 Sep 2026 22.37 23.23 22.08 22.73 +2.39% 1,106,000
14 Sep 2026 – 18 Sep 2026 22.40 23.00 21.99 22.20 -0.89% 1,917,900
08 Sep 2026 – 11 Sep 2026 21.54 22.73 21.29 22.40 +2.42% 1,177,300
253 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
26.82 USD
Market cap
600.9M
Exchange
NasdaqGM
Country
United States
Sector
Healthcare
Industry
Medical Devices
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 16.9 / 25
  • Revenue growth of 10.1% a year
Quality Return on equity, net margin and how stable the margins are. 5.9 / 25
  • ROE of 11%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 20.0 / 20
  • Net debt is -1.4× EBITDA
  • Free cash flow yield of 4.2%
Valuation Free cash flow yield and the P/E against its sector. 11.5 / 15
  • P/E 26.0 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 10.0 / 10
  • Analysts' target is +34% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 26.04× Weak 30.56×
P/E (forward) 18.24× Fair 14.16×
Price / book 2.65× Fair 3.5×
Price / sales 1.69× Good 3.33×
EV / EBITDA 13.4× Fair 11.19×
Free cash flow yield 4.2% Fair 2.1%
Quality
FigureValueReading Sector median
Gross margin 77% Good 54.9%
Operating margin 9.4% Fair 5.8%
Net margin 6.7% Fair 1.2%
Return on equity 11% Fair 4.4%
Return on assets 7.6% Good 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year 10.1% Good 10.1%
Financial health
FigureValueReading Sector median
Debt / equity 0.08× Good 0.4×
Net debt / EBITDA -1.43× Good 1.46×
Interest cover 28.21× Good 2.17×
Current ratio 3.51× Good 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow TCMD and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in